Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana V. Ulloa"'
Autor:
Robert F. Miller, Kieran R. Daly, Peter D. Walzer, Ana V. Ulloa, Carolina A. Ponce, Sergio L. Vargas
Publikováno v:
Journal of Fungi, Vol 8, Iss 2, p 136 (2022)
Previous serologic surveys show >80% of infants in Chile have anti-Pneumocystis antibodies by 2 years of age, but the seroepidemiology of Pneumocystis infection beyond infancy is unknown. We describe the sero-epidemiology in infants, children, and ad
Externí odkaz:
https://doaj.org/article/6855ff0dda9446afb025aa02f2a3ffdd
Autor:
Robert F, Miller, Kieran R, Daly, Peter D, Walzer, Ana V, Ulloa, Carolina A, Ponce, Sergio L, Vargas
Publikováno v:
Journal of fungi (Basel, Switzerland). 8(2)
Previous serologic surveys show80% of infants in Chile have anti
Autor:
Ann E. Wakefield, Juan J. Latorre, Stephen J. Gould, Weitz Jc, Ana V. Ulloa, Walter T. Hughes, Miriam Gallo, Patricio Madrid, Ricardo Avila, Carolina A. Ponce, Sergio Donoso, Samuel Benveniste, Sergio L. Vargas, José Belletti, René Lopez
Publikováno v:
Clinical Infectious Diseases. 29:1489-1493
5 JoseBelletti, 5 P= .002 test). This prompted us to analyze additional series of infants with sudden infant death syn- drome (SIDS). In 161 additional SIDS cases, 47 (35.1%) of 134 infants from Chile and 4 (14.8%) of 27 infants from Oxford, United K
Autor:
Maria P. Muñoz, Susana Prieto, Walter T. Hughes, Sergio L. Vargas, Carolina A. Ponce, Francis Gigliotti, Ana V. Ulloa
Publikováno v:
Journal of Clinical Microbiology. 38:1536-1538
The transmission of Pneumocystis carinii from person to person was studied by detecting P. carinii -specific DNA in prospectively obtained noninvasive deep-nasal-swab samples from a child with a documented P. carinii pneumonia (PCP), his mother, two
Autor:
Guido Juarez, Rebeca Bustamante, Catherine Sánchez, Ana V. Ulloa, Carolina A. Ponce, Sergio L. Vargas
Publikováno v:
Emerging Infectious Diseases, Vol 9, Iss 5, Pp 605-606 (2003)
Emerging Infectious Diseases
ResearcherID
Emerging Infectious Diseases
ResearcherID
To the Editor: Severe immunosuppression is the leading determinant host factor for Pneumocystis pneumonia (PCP) (1). However, PCP is not restricted to those who are severely immunocompromised. Molecular techniques based on the amplification of specif